CRISPR screening in cancer stem cells
- 16 September 2022
- journal article
- review article
- Published by Portland Press Ltd. in Essays in Biochemistry
- Vol. 66 (4), 305-318
- https://doi.org/10.1042/ebc20220009
Abstract
Cancer stem cells (CSCs) are a subpopulation of tumor cells with self-renewal ability. Increasing evidence points to the critical roles of CSCs in tumorigenesis, metastasis, therapy resistance, and cancer relapse. As such, the elimination of CSCs improves cancer treatment outcomes. However, challenges remain due to limited understanding of the molecular mechanisms governing self-renewal and survival of CSCs. Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 screening has been increasingly used to identify genetic determinants in cancers. In this primer, we discuss the progress made and emerging opportunities of coupling advanced CRISPR screening systems with CSC models to reveal the understudied vulnerabilities of CSCs.Keywords
This publication has 101 references indexed in Scilit:
- One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome EngineeringCell, 2013
- Multiplex Genome Engineering Using CRISPR/Cas SystemsScience, 2013
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapiesJCI Insight, 2011
- Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell linesBMC Gastroenterology, 2011
- Recognition and Killing of Brain Tumor Stem-Like Initiating Cells by CD8+ Cytolytic T CellsCancer Research, 2009
- CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosisBritish Journal of Cancer, 2008
- Phenotypic characterization of human colorectal cancer stem cellsProceedings of the National Academy of Sciences of the United States of America, 2007
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Cancer Stem Cells—Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem CellsCancer Research, 2006
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003